EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research progress on the role of ET‐1 in diabetic kidney disease

Shenghao Zhang, Xiaodan Li, Siyu Liu, Wanting Zhang, Meinuo Li, Chen Qiao iD

Journal of Cellular Physiology · 2023-06 · 238 (6) · 1183-1192

DOI: 10.1002/jcp.31023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 17.04.2023. Verfasst von Shenghao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Podocytes, Diabetes Mellitus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is one of the common complications of diabetes mellitus, which usually progresses to end‐stage renal disease and causes great damage to the health of patients. Endothelin‐1 (ET‐1), a molecule closely associated with the progression of DKD, has increased expression in response to high glucose stimulation and is involved in hemodynamic changes, inflammation, glomerular and tubular dysfunction in the kidney, causing an increase in proteinuria and a decrease in glomerular filtration function, ultimately leading to glomerulosclerosis and renal failure. This paper aims to review the molecular level changes, regulatory mechanisms, and mechanisms of action of ET‐1 under DKD, clinical trials of ET‐1 receptor antagonists in recent years and current problems, to provide basic information and new research directions and ideas for the treatment of DKD and ET‐1‐related research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesPodocytesDiabetes MellitusHumansEndothelin-1Kidney GlomerulusKidney

Stichwörter der Autor:innen

ET-1clinical trialsdiabetic kidney diseaseendothelial cellkidney tubulespodocytes

Substanzen

Endothelin-1

Autor:innen und Institutionen

  • School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.

ORCID-Profile: Chen Qiao

Zitieren

APA

Zhang, S., Li, X., Liu, S., Zhang, W., Li, M., & Qiao, C. (2023). Research progress on the role of ET‐1 in diabetic kidney disease. Journal of Cellular Physiology, 238(6), 1183-1192. https://doi.org/10.1002/jcp.31023

Vancouver

Zhang S, Li X, Liu S, Zhang W, Li M, Qiao C. Research progress on the role of ET‐1 in diabetic kidney disease. Journal of Cellular Physiology. 2023;238(6):1183-1192. doi:10.1002/jcp.31023

BibTeX
@article{Zhang2023,
  author = {Zhang, Shenghao and Li, Xiaodan and Liu, Siyu and Zhang, Wanting and Li, Meinuo and Qiao, Chen},
  title = {Research progress on the role of ET‐1 in diabetic kidney disease},
  journal = {Journal of Cellular Physiology},
  year = {2023},
  volume = {238},
  number = {6},
  pages = {1183--1192},
  doi = {10.1002/jcp.31023}
}
Kostenlos starten →